Today: 24 January 2026
Subscribe
Browse Category

Stock Market News 16 December 2025

Venus Concept Inc. (NASDAQ: VERO) Stock: Latest News, Catalysts, and Forecasts as of December 16, 2025

Venus Concept Inc. (NASDAQ: VERO) Stock: Latest News, Catalysts, and Forecasts as of December 16, 2025

Venus Concept Inc. stock (NASDAQ: VERO) is back on traders’ radar in mid-December 2025—less because it’s a calm, steadily compounding story (it isn’t), and more because the company has stacked multiple high-impact catalysts and balance-sheet developments into a tight window. As of the Dec. 15 close, VERO finished around $1.67, down roughly 10.7% on the day, and early Dec. 16…
16 December 2025
····
Inspire Veterinary Partners (IVP) Stock News Today: Nasdaq Delisting Risk, Dilution Signals, and 2026 Catalysts (Dec. 16, 2025)

Inspire Veterinary Partners (IVP) Stock News Today: Nasdaq Delisting Risk, Dilution Signals, and 2026 Catalysts (Dec. 16, 2025)

December 16, 2025 — Inspire Veterinary Partners, Inc. (NASDAQ: IVP) is once again on traders’ radar, but not for the comforting reasons investors typically like in a healthcare-services name. The stock is trading around $0.05 per share in early Tuesday action, after a stretch of extreme volatility driven by Nasdaq listing risk, capital-structure changes, and a growing conversation around potential…
16 December 2025
··
Pfizer Stock (PFE) Today, Dec. 16, 2025: 2026 Guidance Call Looms as Analysts Weigh Dividend, Deal Flow, and Policy Risks

Pfizer Stock (PFE) Today, Dec. 16, 2025: 2026 Guidance Call Looms as Analysts Weigh Dividend, Deal Flow, and Policy Risks

Pfizer Inc. (NYSE: PFE) heads into Tuesday, December 16, 2025 with a familiar “big pharma” cocktail of catalysts: an imminent guidance event, a high dividend yield, fresh dealmaking in hot therapeutic areas (immunology and obesity), and a regulatory backdrop that can flip sentiment faster than a lab centrifuge. Shares closed Monday at $26.43, up 2.24%, extending a four-session winning streak,…
16 December 2025
····
Nektar Therapeutics Stock (NKTR) Surges Into a Major Catalyst: What to Know Ahead of Today’s REZOLVE-AA Data

Nektar Therapeutics Stock (NKTR) Surges Into a Major Catalyst: What to Know Ahead of Today’s REZOLVE-AA Data

Nektar Therapeutics (NASDAQ: NKTR) is in classic “biotech catalyst mode” on December 16, 2025—the kind of day when a single dataset can rewrite a stock chart in minutes. Shares climbed in pre-market and overnight trading as investors positioned for topline results from the 36-week induction period of Nektar’s Phase 2b REZOLVE-AA study in severe-to-very-severe alopecia areata, featuring its lead investigational…
16 December 2025
····
uniQure (QURE) Stock Jumps in Pre-Market on Dec. 16, 2025: FDA AMT-130 Uncertainty, Analyst Price Targets, and Key Catalysts Ahead

uniQure (QURE) Stock Jumps in Pre-Market on Dec. 16, 2025: FDA AMT-130 Uncertainty, Analyst Price Targets, and Key Catalysts Ahead

Dec. 16, 2025 — uniQure N.V. (NASDAQ: QURE) is back in the spotlight Tuesday after a notable extended-hours rebound. The gene therapy developer’s shares were highlighted among top pre-market gainers, rising about 15% to roughly $23.50 in early trading, following a strong after-hours move the prior session. StockAnalysis The snapback comes at a time when the fundamental narrative around uniQure…
16 December 2025
····
Procter & Gamble Stock (PG) News Today: Price Rally Extends, Leadership Shifts, Dividend Outlook and Analyst Forecasts (December 16, 2025)

Procter & Gamble Stock (PG) News Today: Price Rally Extends, Leadership Shifts, Dividend Outlook and Analyst Forecasts (December 16, 2025)

December 16, 2025 — The Procter & Gamble Company (NYSE: PG) is back in the market’s good graces after a choppy year for consumer staples. PG shares finished the latest session up 1.60% at $145.13, extending the stock’s winning streak to five straight days even as the broader market slipped. Marketwatch That near-term momentum is colliding with a very “P&G”…
16 December 2025
····
Affirm Holdings (AFRM) Stock News Today: CFO Fireside Chat, Analyst Targets, and BNPL Scrutiny in Focus (Dec. 16, 2025)

Affirm Holdings (AFRM) Stock News Today: CFO Fireside Chat, Analyst Targets, and BNPL Scrutiny in Focus (Dec. 16, 2025)

December 16, 2025 — Affirm Holdings, Inc. (NASDAQ: AFRM) heads into today with investors watching two forces that can move buy-now-pay-later (BNPL) stocks fast: company messaging and policy risk. Shares closed Monday, Dec. 15 at $65.66, down 2.36% on the day, setting the stage for today’s investor-focused event featuring the company’s CFO. StockAnalysis That event—an interactive CFO fireside chat scheduled…
16 December 2025
···
Singapore Bank Stocks Hit Record Highs on Dec 16, 2025: DBS and OCBC Surge, UOB Lags as Investors Eye Dividends and 2026 Momentum

Singapore Bank Stocks Hit Record Highs on Dec 16, 2025: DBS and OCBC Surge, UOB Lags as Investors Eye Dividends and 2026 Momentum

SINGAPORE — December 16, 2025. Singapore’s bank-heavy equity market delivered a fresh headline on Tuesday: DBS and OCBC both notched new all-time highs, reinforcing a late‑2025 narrative that the “big three” banks remain core holdings for income-focused investors—just as the debate shifts to whether the rally can hold into 2026. The Business Times But the story is bigger than a…
16 December 2025
···
Tesla Stock (TSLA) Surges on Driverless Robotaxi Tests: Latest News, Analyst Forecasts, and Key Risks for December 16, 2025

Tesla Stock (TSLA) Surges on Driverless Robotaxi Tests: Latest News, Analyst Forecasts, and Key Risks for December 16, 2025

Tesla, Inc. (NASDAQ: TSLA) is back at the center of the market conversation on December 16, 2025, after a fresh burst of optimism around the company’s autonomous-driving ambitions pushed shares higher. Tesla stock was trading around $475, up roughly 3.5%, and sitting near the top of its 52‑week range. Investing The catalyst isn’t a new Model Y refresh or a…
16 December 2025
····
Immunome (IMNM) Stock Today: Phase 3 RINGSIDE Win, $400M Offering, and Fresh Analyst Targets (Dec. 16, 2025)

Immunome (IMNM) Stock Today: Phase 3 RINGSIDE Win, $400M Offering, and Fresh Analyst Targets (Dec. 16, 2025)

Immunome, Inc. (NASDAQ: IMNM) is in the spotlight on December 16, 2025, after the company reported positive topline Phase 3 results for its lead desmoid tumor program and then moved to raise significant new capital—two catalysts that can push a biotech stock in opposite directions at the same time. On the one hand: a clear late-stage efficacy win that supports…
16 December 2025
····
Zillow Group Stock (ZG) Drops After Google Tests Home Listings in Search: Analyst Targets, Forecasts and Key Risks (Dec. 16, 2025)

Zillow Group Stock (ZG) Drops After Google Tests Home Listings in Search: Analyst Targets, Forecasts and Key Risks (Dec. 16, 2025)

Zillow Group, Inc. shares are under pressure on Tuesday, December 16, 2025, as investors react to a sudden, very modern fear: what happens if Google decides it wants to “be the front door” to home search, not just the street sign pointing to it? In the latest trading data available Tuesday, Zillow’s Class A shares (NASDAQ: ZG) were down roughly…
16 December 2025
····
India Markets Today: Rupee Breaks 91 per Dollar, Stocks Slip as Trade-Talk Uncertainty Collides With a Deal-and-Realty Wave

India Markets Today: Rupee Breaks 91 per Dollar, Stocks Slip as Trade-Talk Uncertainty Collides With a Deal-and-Realty Wave

On December 16, 2025, India’s financial markets were forced to juggle two powerful (and competing) narratives: The result: a classic “macro vs micro” day—macro pressure from FX, flows, and trade policy uncertainty… meeting micro momentum from corporate actions, listings, and sector upcycles (including real estate). Rupee crosses 91: what happened, and why it mattered immediately The rupee breached ₹91/$ on…
16 December 2025
··
1 … 884 885 886 887 888 … 1,575

Stock Market Today

  • Earnings vs. Stock Market: Understanding the Disconnect
    January 23, 2026, 6:55 PM EST. Corporate earnings and the stock market often move independently, posing challenges for investors. Market prices reflect not only current profits but also expectations about the future, influenced by economic conditions, sentiment, and external shocks. This disconnect means strong earnings do not always translate into rising stock prices. Investors must parse signals beyond earnings reports, considering factors like interest rates and geopolitical risks. Awareness of this complexity can help in navigating market volatility and making informed investment decisions.
Go toTop